1,2-dimethylhydrazine increases expression ISO RGD:62145 6480464 1, 2-Dimethylhydrazine results in increased expression of GPC1 mRNA CTD PMID:22206623 1,3,5-trinitro-1,3,5-triazinane increases expression EXP 6480464 cyclonite results in increased expression of GPC1 mRNA CTD PMID:25559034 17alpha-ethynylestradiol increases expression ISO RGD:62145 6480464 Ethinyl Estradiol results in increased expression of GPC1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of GPC1 mRNA CTD PMID:17557909 17alpha-ethynylestradiol multiple interactions ISO RGD:62145 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GPC1 mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO RGD:730930 6480464 Estradiol affects the expression of GPC1 mRNA CTD PMID:22574217 17beta-estradiol multiple interactions ISO RGD:730930 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of GPC1 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:62145 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GPC1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62145 6480464 Tetrachlorodibenzodioxin affects the expression of GPC1 mRNA CTD PMID:21570461 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62145 6480464 Tetrachlorodibenzodioxin results in increased expression of GPC1 mRNA CTD PMID:15667827 more ... 2,4-diaminotoluene increases expression ISO RGD:62145 6480464 2, 4-diaminotoluene results in increased expression of GPC1 mRNA CTD PMID:20713471 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:62145 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of GPC1 mRNA CTD PMID:16054899 3-methylcholanthrene increases expression ISO RGD:62145 6480464 Methylcholanthrene results in increased expression of GPC1 mRNA CTD PMID:20713471 3beta-(2-diethylaminoethoxy)androst-5-en-17-one hydrochloride decreases degradation ISO RGD:62145 6480464 3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one results in decreased degradation of GPC1 protein CTD PMID:21642435 4,4'-diaminodiphenylmethane increases expression ISO RGD:62145 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GPC1 mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide decreases expression ISO RGD:62145 6480464 Fenretinide results in decreased expression of GPC1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GPC1 mRNA CTD PMID:25825206 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of GPC1 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:730930 6480464 Aflatoxin B1 results in increased expression of GPC1 mRNA CTD PMID:21632981 , PMID:21641981 aflatoxin B1 increases methylation ISO RGD:730930 6480464 Aflatoxin B1 results in increased methylation of GPC1 intron CTD PMID:30157460 antimycin A decreases expression ISO RGD:730930 6480464 Antimycin A results in decreased expression of GPC1 mRNA CTD PMID:33512557 arsenite(3-) multiple interactions ISO RGD:62145 6480464 [arsenite co-treated with Benzo(a)pyrene] results in increased expression of GPC1 mRNA CTD PMID:15894712 arsenite(3-) increases expression ISO RGD:62145 6480464 arsenite results in increased expression of GPC1 mRNA CTD PMID:15894712 arsenous acid increases expression ISO RGD:730930 6480464 Arsenic Trioxide results in increased expression of GPC1 mRNA CTD PMID:25555879 azoxystrobin decreases expression ISO RGD:730930 6480464 azoxystrobin results in decreased expression of GPC1 mRNA CTD PMID:33512557 benzo[a]pyrene increases expression ISO RGD:62145 6480464 Benzo(a)pyrene results in increased expression of GPC1 mRNA CTD PMID:15894712 , PMID:20713471 benzo[a]pyrene increases methylation ISO RGD:730930 6480464 Benzo(a)pyrene results in increased methylation of GPC1 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:730930 6480464 Benzo(a)pyrene results in increased expression of GPC1 mRNA CTD PMID:20064835 more ... benzo[a]pyrene decreases expression ISO RGD:62145 6480464 Benzo(a)pyrene results in decreased expression of GPC1 mRNA CTD PMID:22228805 benzo[a]pyrene multiple interactions ISO RGD:62145 6480464 [arsenite co-treated with Benzo(a)pyrene] results in increased expression of GPC1 mRNA CTD PMID:15894712 bicalutamide decreases expression ISO RGD:730930 6480464 bicalutamide results in decreased expression of GPC1 mRNA CTD PMID:15638997 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GPC1 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:730930 6480464 bisphenol A results in increased methylation of GPC1 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:730930 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of GPC1 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:62145 6480464 bisphenol A results in increased expression of GPC1 mRNA CTD PMID:32370801 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GPC1 mRNA CTD PMID:33296240 butan-1-ol multiple interactions ISO RGD:730930 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GPC1 mRNA CTD PMID:29432896 cadmium atom decreases expression ISO RGD:62145 6480464 Cadmium results in decreased expression of GPC1 mRNA CTD PMID:23358151 cadmium atom increases expression ISO RGD:730930 6480464 Cadmium results in increased expression of GPC1 mRNA CTD PMID:24376830 carbon nanotube increases expression ISO RGD:62145 6480464 Nanotubes, Carbon results in increased expression of GPC1 mRNA CTD PMID:25554681 choline multiple interactions ISO RGD:62145 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of GPC1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPC1 mRNA CTD PMID:20938992 , PMID:29127188 cisplatin multiple interactions ISO RGD:730930 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of GPC1 mRNA CTD PMID:21858171 clofibrate decreases expression ISO RGD:62145 6480464 Clofibrate results in decreased expression of GPC1 mRNA CTD PMID:17585979 copper atom multiple interactions ISO RGD:62145 6480464 [APLP2 protein co-treated with Copper] results in decreased degradation of GPC1 protein modified form more ... CTD PMID:15677459 more ... copper atom increases expression EXP 6480464 Copper results in increased expression of GPC1 mRNA CTD PMID:30556269 copper atom affects binding ISO RGD:62145 6480464 GPC1 protein binds to Copper CTD PMID:12732622 copper atom increases oxidation ISO RGD:62145 6480464 GPC1 protein results in increased oxidation of Copper CTD PMID:12732622 copper atom increases reduction ISO RGD:62145 6480464 GPC1 protein modified form results in increased reduction of Copper CTD PMID:12732622 copper(0) multiple interactions ISO RGD:62145 6480464 [APLP2 protein co-treated with Copper] results in decreased degradation of GPC1 protein modified form more ... CTD PMID:15677459 more ... copper(0) increases expression EXP 6480464 Copper results in increased expression of GPC1 mRNA CTD PMID:30556269 copper(0) affects binding ISO RGD:62145 6480464 GPC1 protein binds to Copper CTD PMID:12732622 copper(0) increases oxidation ISO RGD:62145 6480464 GPC1 protein results in increased oxidation of Copper CTD PMID:12732622 copper(0) increases reduction ISO RGD:62145 6480464 GPC1 protein modified form results in increased reduction of Copper CTD PMID:12732622 crocidolite asbestos increases expression ISO RGD:730930 6480464 Asbestos, Crocidolite results in increased expression of GPC1 protein CTD PMID:29553831 cyclosporin A increases expression ISO RGD:730930 6480464 Cyclosporine results in increased expression of GPC1 mRNA CTD PMID:20106945 , PMID:25562108 deguelin decreases expression ISO RGD:730930 6480464 deguelin results in decreased expression of GPC1 mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO RGD:62145 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of GPC1 mRNA CTD PMID:16054899 diarsenic trioxide increases expression ISO RGD:730930 6480464 Arsenic Trioxide results in increased expression of GPC1 mRNA CTD PMID:25555879 diazinon increases methylation ISO RGD:730930 6480464 Diazinon results in increased methylation of GPC1 gene CTD PMID:22964155 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of GPC1 mRNA CTD PMID:21266533 dioxygen increases expression ISO RGD:62145 6480464 Oxygen deficiency results in increased expression of GPC1 mRNA CTD PMID:24205000 disodium selenite increases expression ISO RGD:730930 6480464 Sodium Selenite results in increased expression of GPC1 mRNA CTD PMID:18175754 doxorubicin decreases expression ISO RGD:62145 6480464 Doxorubicin results in decreased expression of GPC1 mRNA CTD PMID:19073829 Echimidine decreases expression EXP 6480464 echimidine results in decreased expression of GPC1 mRNA CTD PMID:34185104 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of GPC1 mRNA CTD PMID:29391264 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of GPC1 mRNA CTD PMID:28454766 epoxiconazole increases expression ISO RGD:62145 6480464 epoxiconazole results in increased expression of GPC1 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:730930 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GPC1 mRNA CTD PMID:29432896 ethanol affects expression ISO RGD:62145 6480464 Ethanol affects the expression of GPC1 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:62145 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of GPC1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPC1 mRNA CTD PMID:20938992 , PMID:29127188 fulvestrant multiple interactions ISO RGD:730930 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of GPC1 gene CTD PMID:31601247 Heliotrine decreases expression EXP 6480464 heliotrine results in decreased expression of GPC1 mRNA CTD PMID:34185104 heparan sulfate affects binding ISO RGD:62145 6480464 GPC1 protein binds to Heparitin Sulfate CTD PMID:12732622 heparan sulfate multiple interactions ISO RGD:62145 6480464 GPC1 protein modified form results in increased cleavage of [GPC1 protein binds to Heparitin Sulfate] more ... CTD PMID:12732622 isobutanol multiple interactions ISO RGD:730930 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GPC1 mRNA CTD PMID:29432896 ivermectin decreases expression ISO RGD:730930 6480464 Ivermectin results in decreased expression of GPC1 protein CTD PMID:32959892 L-ascorbic acid multiple interactions ISO RGD:62145 6480464 [Ascorbic Acid co-treated with Nitric Oxide] results in increased degradation of GPC1 protein modified form, Zinc promotes the reaction [[Ascorbic Acid co-treated with Nitric Oxide] results in increased degradation of GPC1 protein modified form] CTD PMID:15677459 L-ascorbic acid increases degradation ISO RGD:62145 6480464 Ascorbic Acid results in increased degradation of GPC1 protein CTD PMID:21642435 L-ascorbic acid increases expression ISO RGD:730930 6480464 Ascorbic Acid results in increased expression of GPC1 mRNA CTD PMID:25555879 L-methionine multiple interactions ISO RGD:62145 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of GPC1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPC1 mRNA CTD PMID:20938992 , PMID:29127188 lead(0) decreases expression ISO RGD:730930 6480464 Lead results in decreased expression of GPC1 mRNA CTD PMID:19921347 lead(0) affects expression ISO RGD:730930 6480464 Lead affects the expression of GPC1 mRNA CTD PMID:28903495 lead(2+) decreases expression ISO RGD:730930 6480464 Lead results in decreased expression of GPC1 mRNA CTD PMID:19921347 lead(2+) affects expression ISO RGD:730930 6480464 Lead affects the expression of GPC1 mRNA CTD PMID:28903495 linuron decreases expression EXP 6480464 Linuron results in decreased expression of GPC1 mRNA CTD PMID:12730624 nitric oxide increases nitrosation ISO RGD:62145 6480464 Nitric Oxide results in increased nitrosation of GPC1 protein CTD PMID:16923158 nitric oxide multiple interactions ISO RGD:62145 6480464 [Ascorbic Acid co-treated with Nitric Oxide] results in increased degradation of GPC1 protein modified form, Zinc promotes the reaction [[Ascorbic Acid co-treated with Nitric Oxide] results in increased degradation of GPC1 protein modified form] CTD PMID:15677459 nitroxyl multiple interactions ISO RGD:62145 6480464 nitroxyl affects the reaction [GPC1 protein results in increased cleavage of [GPC1 protein binds to Heparitin Sulfate]] CTD PMID:12732622 ochratoxin A multiple interactions ISO RGD:730930 6480464 [ochratoxin A results in increased acetylation of GPC1 promoter] which results in increased expression of GPC1 mRNA CTD PMID:29098329 ochratoxin A increases acetylation ISO RGD:730930 6480464 ochratoxin A results in increased acetylation of GPC1 promoter CTD PMID:29098329 ochratoxin A increases expression ISO RGD:730930 6480464 ochratoxin A results in increased expression of GPC1 mRNA CTD PMID:29098329 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of GPC1 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GPC1 mRNA CTD PMID:25729387 ozone decreases expression EXP 6480464 Ozone results in decreased expression of GPC1 mRNA CTD PMID:16330353 ozone multiple interactions ISO RGD:62145 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of GPC1 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:730930 6480464 Acetaminophen results in increased expression of GPC1 mRNA CTD PMID:22230336 , PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GPC1 mRNA CTD PMID:33387578 paraquat affects expression EXP 6480464 Paraquat affects the expression of GPC1 mRNA CTD PMID:15206577 phenobarbital multiple interactions ISO RGD:62145 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of GPC1 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:62145 6480464 Phenobarbital affects the expression of GPC1 mRNA CTD PMID:23091169 phenobarbital decreases expression ISO RGD:62145 6480464 Phenobarbital results in decreased expression of GPC1 mRNA CTD PMID:19482888 picoxystrobin decreases expression ISO RGD:730930 6480464 picoxystrobin results in decreased expression of GPC1 mRNA CTD PMID:33512557 piroxicam multiple interactions ISO RGD:730930 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of GPC1 mRNA CTD PMID:21858171 pyrimidifen decreases expression ISO RGD:730930 6480464 pyrimidifen results in decreased expression of GPC1 mRNA CTD PMID:33512557 quercetin increases expression ISO RGD:730930 6480464 Quercetin results in increased expression of GPC1 mRNA CTD PMID:21632981 raloxifene affects expression ISO RGD:730930 6480464 Raloxifene Hydrochloride affects the expression of GPC1 mRNA CTD PMID:14699072 resveratrol decreases expression ISO RGD:62145 6480464 resveratrol results in decreased expression of GPC1 protein CTD PMID:25505154 rotenone decreases expression ISO RGD:730930 6480464 Rotenone results in decreased expression of GPC1 mRNA CTD PMID:33512557 senecionine decreases expression EXP 6480464 senecionine results in decreased expression of GPC1 mRNA CTD PMID:34185104 silicon dioxide affects secretion ISO RGD:730930 6480464 Silicon Dioxide analog affects the secretion of GPC1 protein CTD PMID:25895662 sodium arsenate decreases expression ISO RGD:62145 6480464 sodium arsenate results in decreased expression of GPC1 mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:730930 6480464 sodium arsenite results in increased expression of GPC1 mRNA CTD PMID:34032870 streptozocin multiple interactions ISO RGD:62145 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of GPC1 mRNA CTD PMID:29127188 sulforaphane increases expression ISO RGD:730930 6480464 sulforaphane results in increased expression of GPC1 mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:730930 6480464 Sunitinib results in decreased expression of GPC1 mRNA CTD PMID:31533062 tamoxifen increases expression ISO RGD:62145 6480464 Tamoxifen results in increased expression of GPC1 mRNA CTD PMID:25123088 tamoxifen affects expression ISO RGD:730930 6480464 Tamoxifen affects the expression of GPC1 mRNA CTD PMID:14699072 tebufenpyrad decreases expression ISO RGD:730930 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of GPC1 mRNA CTD PMID:33512557 temozolomide decreases expression ISO RGD:730930 6480464 Temozolomide results in decreased expression of GPC1 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO RGD:62145 6480464 tert-Butylhydroperoxide results in increased expression of GPC1 mRNA CTD PMID:15003993 testosterone affects expression ISO RGD:62145 6480464 Testosterone affects the expression of GPC1 mRNA CTD PMID:20403060 testosterone enanthate affects expression ISO RGD:730930 6480464 testosterone enanthate affects the expression of GPC1 mRNA CTD PMID:17440010 tetrachloromethane affects expression ISO RGD:62145 6480464 Carbon Tetrachloride affects the expression of GPC1 mRNA CTD PMID:17484886 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GPC1 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:62145 6480464 titanium dioxide results in decreased expression of GPC1 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GPC1 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of GPC1 mRNA CTD PMID:25729387 trovafloxacin increases expression ISO RGD:62145 6480464 trovafloxacin results in increased expression of GPC1 mRNA CTD PMID:35537566 valproic acid affects expression ISO RGD:62145 6480464 Valproic Acid affects the expression of GPC1 mRNA CTD PMID:17963808 valproic acid increases methylation ISO RGD:730930 6480464 Valproic Acid results in increased methylation of GPC1 gene CTD PMID:29154799 vorinostat decreases expression ISO RGD:730930 6480464 vorinostat results in decreased expression of GPC1 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:62145 6480464 [APP protein co-treated with Zinc] results in increased degradation of GPC1 protein modified form more ... CTD PMID:12732622 , PMID:15677459 zinc(0) multiple interactions ISO RGD:62145 6480464 [APP protein co-treated with Zinc] results in increased degradation of GPC1 protein modified form more ... CTD PMID:12732622 , PMID:15677459
